Publication Name	World Journal of Clinical Cases
Manuscript ID	10330
Country	Spain

Received	2014-03-27 10:22
Peer-Review Started	2014-04-01 09:11
To Make the First Decision	2014-04-15 15:18
Return for Revision	2014-04-16 14:39
Revised	2014-04-30 17:04
Second Decision	2014-07-14 17:08
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-07-14 17:32
Articles in Press	2014-07-14 17:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-09-05 11:01
Publish the Manuscript Online	2014-09-25 13:15

ISSN	2307-8960 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen
Manuscript Source	Invited Manuscript
All Author List	Juan J Chillarón, Juana A Flores-Le Roux, David Benaiges and Juan Pedro-Botet
Funding Agency and Grant Number
Corresponding Author	Dr. Juan José Chillarón, Department of Endocrinology and Nutrition, Hospital del Mar, Passeig Marítim, 25-29, 08003 Barcelona, Spain. jchillaron@parcdesalutmar.cat
Key Words	Cardiovascular disease; Type 2 Diabetes Mellitus
Core Tip	The prevalence of type 2 diabetes mellitus (T2DM) has risen in recent decades, and cardiovascular disease remains the leading cause of death in this population. Several clinical trials have demonstrated the benefit of tight control of risk factors on the incidence and mortality of cardiovascular disease. The current diagnostic procedures for subclinical cardiovascular disease in T2DM patients have not been shown to improve prognosis or mortality, probably because they do not categorize cardiovascular risk. Improvements in the reliability of diagnostic tests, with fewer side effects and better cost efficiency, may better help to stratify cardiovascular risk in this group of patients, and further evaluation on this topic should be considered.
Publish Date	2014-09-25 13:15
Citation	Chillarón JJ, Flores-Le Roux JA, Benaiges D, Pedro-Botet J. Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen. World J Clin Cases 2014; 2(9): 415-421
URL	http://www.wjgnet.com/2307-8960/full/v2/i9/415.htm
DOI	http://dx.doi.org/10.12998/wjcc.v2.i9.415

Full Article (PDF)	WJCC-2-415.pdf
Full Article (Word)	WJCC-2-415.doc
Manuscript File	10330-Review.doc
Answering Reviewers	10330-Answering reviewers.pdf
Copyright License Agreement	10330-Copyright assignment.pdf
Peer-review Report	10330-Peer review(s).pdf
Scientific Misconduct Check	10330-CrossCheck.jpg
Scientific Editor Work List	10330-Scientific editor work list.pdf